APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rapid Influenza Diagnostic Test (RIDT)

Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.

Selected research

Industry Growth & Trends

Global Rapid Influenza Diagnostic Test (RIDT) Industry Growth and Trends Forecast to 2032

19 December 2025113 pages

Choose your research edition.

Industry ResearchRapid Influenza Diagnostic Test (RIDT) Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Rapid Influenza Diagnostic Test (RIDT) Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Rapid Influenza Diagnostic Test (RIDT) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rapid Influenza Diagnostic Test (RIDT) Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Rapid Influenza Diagnostic Test (RIDT) Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.

According to APO Research, the global Rapid Influenza Diagnostic Test (RIDT) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Rapid Influenza Diagnostic Test (RIDT) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Rapid Influenza Diagnostic Test (RIDT) market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Rapid Influenza Diagnostic Test (RIDT) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Rapid Influenza Diagnostic Test (RIDT).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Rapid Influenza Diagnostic Test (RIDT) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Rapid Influenza Diagnostic Test (RIDT) Market by Company

BD

Abbot (Alere)

Quidel

Roche

Thermo Fisher Scientific

Meridian Bioscience

Analytik Jena

Princeton BioMeditech Corporation

BioMerieux

Sekisui Diagnostics

Response Biomedical

SA Scientific

DiaSorin (Focus Diagnostics)

Wondfo

Beijing Wantai Biological Pharmacy

Rapid Influenza Diagnostic Test (RIDT) Segment by Type

Digital RIDTs

Conventional RIDT

Rapid Influenza Diagnostic Test (RIDT) Segment by Application

Hospitals

POCT

Others

Rapid Influenza Diagnostic Test (RIDT) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rapid Influenza Diagnostic Test (RIDT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rapid Influenza Diagnostic Test (RIDT) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rapid Influenza Diagnostic Test (RIDT).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Rapid Influenza Diagnostic Test (RIDT) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Rapid Influenza Diagnostic Test (RIDT) Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Rapid Influenza Diagnostic Test (RIDT) Market Share by Region (2021-2026) Table 4. Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Rapid Influenza Diagnostic Test (RIDT) Market Share by Region (2027-2032) Table 6. Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Rapid Influenza Diagnostic Test (RIDT) Market Size Share by Type (2021-2026) Table 9. Global Rapid Influenza Diagnostic Test (RIDT) Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Rapid Influenza Diagnostic Test (RIDT) Market Size Share Forecasted by Type (2027-2032) Table 11. North America Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Rapid Influenza Diagnostic Test (RIDT) Market Size Share by Application (2021-2026) Table 24. Global Rapid Influenza Diagnostic Test (RIDT) Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Rapid Influenza Diagnostic Test (RIDT) Market Size Share Forecasted by Application (2027-2032) Table 26. North America Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Rapid Influenza Diagnostic Test (RIDT) Industry Trends Table 37. Rapid Influenza Diagnostic Test (RIDT) Industry Drivers Table 38. Rapid Influenza Diagnostic Test (RIDT) Industry Opportunities and Challenges Table 39. Rapid Influenza Diagnostic Test (RIDT) Industry Restraints Table 40. Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Company (2021-2026) Table 42. Global Rapid Influenza Diagnostic Test (RIDT) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Rapid Influenza Diagnostic Test (RIDT) Key Company Headquarters & Area Served Table 44. Global Rapid Influenza Diagnostic Test (RIDT) Company, Product Type & Application Table 45. Global Rapid Influenza Diagnostic Test (RIDT) Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Rapid Influenza Diagnostic Test (RIDT) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. BD Company Information Table 49. BD Business Overview Table 50. BD Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. BD Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 52. BD Recent Development Table 53. Abbot (Alere) Company Information Table 54. Abbot (Alere) Business Overview Table 55. Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 57. Abbot (Alere) Recent Development Table 58. Quidel Company Information Table 59. Quidel Business Overview Table 60. Quidel Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Quidel Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 62. Quidel Recent Development Table 63. Roche Company Information Table 64. Roche Business Overview Table 65. Roche Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Roche Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 67. Roche Recent Development Table 68. Thermo Fisher Scientific Company Information Table 69. Thermo Fisher Scientific Business Overview Table 70. Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 72. Thermo Fisher Scientific Recent Development Table 73. Meridian Bioscience Company Information Table 74. Meridian Bioscience Business Overview Table 75. Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 77. Meridian Bioscience Recent Development Table 78. Analytik Jena Company Information Table 79. Analytik Jena Business Overview Table 80. Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 82. Analytik Jena Recent Development Table 83. Princeton BioMeditech Corporation Company Information Table 84. Princeton BioMeditech Corporation Business Overview Table 85. Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 87. Princeton BioMeditech Corporation Recent Development Table 88. BioMerieux Company Information Table 89. BioMerieux Business Overview Table 90. BioMerieux Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. BioMerieux Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 92. BioMerieux Recent Development Table 93. Sekisui Diagnostics Company Information Table 94. Sekisui Diagnostics Business Overview Table 95. Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 97. Sekisui Diagnostics Recent Development Table 98. Response Biomedical Company Information Table 99. Response Biomedical Business Overview Table 100. Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 102. Response Biomedical Recent Development Table 103. SA Scientific Company Information Table 104. SA Scientific Business Overview Table 105. SA Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. SA Scientific Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 107. SA Scientific Recent Development Table 108. DiaSorin (Focus Diagnostics) Company Information Table 109. DiaSorin (Focus Diagnostics) Business Overview Table 110. DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 112. DiaSorin (Focus Diagnostics) Recent Development Table 113. Wondfo Company Information Table 114. Wondfo Business Overview Table 115. Wondfo Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Wondfo Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 117. Wondfo Recent Development Table 118. Beijing Wantai Biological Pharmacy Company Information Table 119. Beijing Wantai Biological Pharmacy Business Overview Table 120. Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 122. Beijing Wantai Biological Pharmacy Recent Development Table 123. North America Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Rapid Influenza Diagnostic Test (RIDT) Market Share by Country (2021-2026) Table 126. North America Rapid Influenza Diagnostic Test (RIDT) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Rapid Influenza Diagnostic Test (RIDT) Market Share Forecast by Country (2027-2032) Table 128. Europe Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Rapid Influenza Diagnostic Test (RIDT) Market Share by Country (2021-2026) Table 131. Europe Rapid Influenza Diagnostic Test (RIDT) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Rapid Influenza Diagnostic Test (RIDT) Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Share by Country (2021-2026) Table 136. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Share Forecast by Country (2027-2032) Table 138. Latin America Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Rapid Influenza Diagnostic Test (RIDT) Market Share by Country (2021-2026) Table 141. Latin America Rapid Influenza Diagnostic Test (RIDT) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Rapid Influenza Diagnostic Test (RIDT) Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Share by Country (2021-2026) Table 146. Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Rapid Influenza Diagnostic Test (RIDT) Product Image Figure 3. Global Rapid Influenza Diagnostic Test (RIDT) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Rapid Influenza Diagnostic Test (RIDT) Market Size (2021-2032) & (US$ Million) Figure 5. Global Rapid Influenza Diagnostic Test (RIDT) Market Share by Region: 2025 VS 2032 Figure 6. Global Rapid Influenza Diagnostic Test (RIDT) Market Share by Region (2021-2032) Figure 7. North America Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Digital RIDTs Image Figure 13. Global Digital RIDTs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Conventional RIDT Image Figure 15. Global Conventional RIDT Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Rapid Influenza Diagnostic Test (RIDT) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Rapid Influenza Diagnostic Test (RIDT) Market Share by Type 2025 VS 2032 Figure 18. North America Rapid Influenza Diagnostic Test (RIDT) Market Size Share by Type (2021-2032) Figure 19. Europe Rapid Influenza Diagnostic Test (RIDT) Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size Share by Type (2021-2032) Figure 21. Latin America Rapid Influenza Diagnostic Test (RIDT) Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Market Size Share by Type (2021-2032) Figure 23. Hospitals Image Figure 24. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. POCT Image Figure 26. Global POCT Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Others Image Figure 28. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Rapid Influenza Diagnostic Test (RIDT) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Rapid Influenza Diagnostic Test (RIDT) Market Share by Application 2025 VS 2032 Figure 31. North America Rapid Influenza Diagnostic Test (RIDT) Market Size Share by Application (2021-2032) Figure 32. Europe Rapid Influenza Diagnostic Test (RIDT) Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size Share by Application (2021-2032) Figure 34. Latin America Rapid Influenza Diagnostic Test (RIDT) Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Rapid Influenza Diagnostic Test (RIDT) Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Rapid Influenza Diagnostic Test (RIDT) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Rapid Influenza Diagnostic Test (RIDT) Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Rapid Influenza Diagnostic Test (RIDT) Market Share by Country (2021-2032) Figure 41. Europe Rapid Influenza Diagnostic Test (RIDT) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Rapid Influenza Diagnostic Test (RIDT) Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Rapid Influenza Diagnostic Test (RIDT) Market Share by Country (2021-2032) Figure 44. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Share by Country (2021-2032) Figure 47. Latin America Rapid Influenza Diagnostic Test (RIDT) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Rapid Influenza Diagnostic Test (RIDT) Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Rapid Influenza Diagnostic Test (RIDT) Market Share by Country (2021-2032) Figure 50. Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Digital RIDTs
  • Conventional RIDT
Applications
  • Hospitals
  • POCT
  • Others
Companies covered
  • BD
  • Abbot (Alere)
  • Quidel
  • Roche
  • Thermo Fisher Scientific
  • Meridian Bioscience
  • Analytik Jena
  • Princeton BioMeditech Corporation
  • BioMerieux
  • Sekisui Diagnostics
  • Response Biomedical
  • SA Scientific
  • DiaSorin (Focus Diagnostics)
  • Wondfo
  • Beijing Wantai Biological Pharmacy

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Rapid Influenza Diagnostic Test (RIDT) Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Region (2021-2032)
  5. 1.4.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Region (2021-2026)
  6. 1.4.2 Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Region (2027-2032)
  7. 1.5 Key Regions Rapid Influenza Diagnostic Test (RIDT) Market Size (2021-2032)
  8. 1.5.1 North America Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate (2021-2032)
2 Rapid Influenza Diagnostic Test (RIDT) Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Digital RIDTs
  3. 2.1.2 Conventional RIDT
  4. 2.2 Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Type
  5. 2.2.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Rapid Influenza Diagnostic Test (RIDT) Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Rapid Influenza Diagnostic Test (RIDT) Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Regions
  9. 2.3.1 North America Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Type (2021-2026)
3 Rapid Influenza Diagnostic Test (RIDT) Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospitals
  3. 3.1.2 POCT
  4. 3.1.3 Others
  5. 3.2 Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Application
  6. 3.2.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Rapid Influenza Diagnostic Test (RIDT) Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Rapid Influenza Diagnostic Test (RIDT) Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Regions
  10. 3.3.1 North America Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Rapid Influenza Diagnostic Test (RIDT) Industry Trends
  2. 4.2 Rapid Influenza Diagnostic Test (RIDT) Industry Drivers
  3. 4.3 Rapid Influenza Diagnostic Test (RIDT) Industry Opportunities and Challenges
  4. 4.4 Rapid Influenza Diagnostic Test (RIDT) Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Rapid Influenza Diagnostic Test (RIDT) Revenue (2021-2026)
  2. 5.2 Global Rapid Influenza Diagnostic Test (RIDT) Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Rapid Influenza Diagnostic Test (RIDT) Key Company Headquarters & Area Served
  4. 5.4 Global Rapid Influenza Diagnostic Test (RIDT) Company, Product Type & Application
  5. 5.5 Global Rapid Influenza Diagnostic Test (RIDT) Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Rapid Influenza Diagnostic Test (RIDT) Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Rapid Influenza Diagnostic Test (RIDT) Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Rapid Influenza Diagnostic Test (RIDT) Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 BD
  2. 6.1.1 BD Company Information
  3. 6.1.2 BD Business Overview
  4. 6.1.3 BD Rapid Influenza Diagnostic Test (RIDT) Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 BD Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  6. 6.1.5 BD Recent Developments
  7. 6.2 Abbot (Alere)
  8. 6.2.1 Abbot (Alere) Company Information
  9. 6.2.2 Abbot (Alere) Business Overview
  10. 6.2.3 Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  12. 6.2.5 Abbot (Alere) Recent Developments
  13. 6.3 Quidel
  14. 6.3.1 Quidel Company Information
  15. 6.3.2 Quidel Business Overview
  16. 6.3.3 Quidel Rapid Influenza Diagnostic Test (RIDT) Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Quidel Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  18. 6.3.5 Quidel Recent Developments
  19. 6.4 Roche
  20. 6.4.1 Roche Company Information
  21. 6.4.2 Roche Business Overview
  22. 6.4.3 Roche Rapid Influenza Diagnostic Test (RIDT) Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Roche Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  24. 6.4.5 Roche Recent Developments
  25. 6.5 Thermo Fisher Scientific
  26. 6.5.1 Thermo Fisher Scientific Company Information
  27. 6.5.2 Thermo Fisher Scientific Business Overview
  28. 6.5.3 Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  30. 6.5.5 Thermo Fisher Scientific Recent Developments
  31. 6.6 Meridian Bioscience
  32. 6.6.1 Meridian Bioscience Company Information
  33. 6.6.2 Meridian Bioscience Business Overview
  34. 6.6.3 Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  36. 6.6.5 Meridian Bioscience Recent Developments
  37. 6.7 Analytik Jena
  38. 6.7.1 Analytik Jena Company Information
  39. 6.7.2 Analytik Jena Business Overview
  40. 6.7.3 Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  42. 6.7.5 Analytik Jena Recent Developments
  43. 6.8 Princeton BioMeditech Corporation
  44. 6.8.1 Princeton BioMeditech Corporation Company Information
  45. 6.8.2 Princeton BioMeditech Corporation Business Overview
  46. 6.8.3 Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  48. 6.8.5 Princeton BioMeditech Corporation Recent Developments
  49. 6.9 BioMerieux
  50. 6.9.1 BioMerieux Company Information
  51. 6.9.2 BioMerieux Business Overview
  52. 6.9.3 BioMerieux Rapid Influenza Diagnostic Test (RIDT) Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 BioMerieux Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  54. 6.9.5 BioMerieux Recent Developments
  55. 6.10 Sekisui Diagnostics
  56. 6.10.1 Sekisui Diagnostics Company Information
  57. 6.10.2 Sekisui Diagnostics Business Overview
  58. 6.10.3 Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  60. 6.10.5 Sekisui Diagnostics Recent Developments
  61. 6.11 Response Biomedical
  62. 6.11.1 Response Biomedical Company Information
  63. 6.11.2 Response Biomedical Business Overview
  64. 6.11.3 Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  66. 6.11.5 Response Biomedical Recent Developments
  67. 6.12 SA Scientific
  68. 6.12.1 SA Scientific Company Information
  69. 6.12.2 SA Scientific Business Overview
  70. 6.12.3 SA Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 SA Scientific Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  72. 6.12.5 SA Scientific Recent Developments
  73. 6.13 DiaSorin (Focus Diagnostics)
  74. 6.13.1 DiaSorin (Focus Diagnostics) Company Information
  75. 6.13.2 DiaSorin (Focus Diagnostics) Business Overview
  76. 6.13.3 DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  78. 6.13.5 DiaSorin (Focus Diagnostics) Recent Developments
  79. 6.14 Wondfo
  80. 6.14.1 Wondfo Company Information
  81. 6.14.2 Wondfo Business Overview
  82. 6.14.3 Wondfo Rapid Influenza Diagnostic Test (RIDT) Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Wondfo Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  84. 6.14.5 Wondfo Recent Developments
  85. 6.15 Beijing Wantai Biological Pharmacy
  86. 6.15.1 Beijing Wantai Biological Pharmacy Company Information
  87. 6.15.2 Beijing Wantai Biological Pharmacy Business Overview
  88. 6.15.3 Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  90. 6.15.5 Beijing Wantai Biological Pharmacy Recent Developments
7 North America
  1. 7.1 North America Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2021-2026)
  3. 7.3 North America Rapid Influenza Diagnostic Test (RIDT) Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2021-2026)
  3. 8.3 Europe Rapid Influenza Diagnostic Test (RIDT) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2021-2026)
  3. 10.3 South America Rapid Influenza Diagnostic Test (RIDT) Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst